Closing a Diagnostic Gap for Chronic Diarrhea


Answers From the Lab

Published September 17, 2026

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.

  • Survey highlights laboratory growth strategies (00:29): Discover where laboratory leaders are investing, the challenges shaping the industry, and the strategies organizations are adopting to achieve sustainable growth.
  • Seasonal viruses and vaccination planning (05:29): Discover how to learn more about vaccination options for viruses that typically surge during the fall and winter.
  • Diagnostics for chronic diarrhea (07:43): Hear how a novel test is improving diagnosis and advancing understanding of bile acid malabsorption.

Note: Information in this post was accurate at the time of its posting.

Resources

Connect with Us

  • Is there a question or topic you’d like us to explore in a future episode? Email us at mayocliniclabs@mayo.edu.
  • Learn more about our hosts and guests and connect with them on social media.

Subscribe

Mayo Clinic Laboratories’ “Answers From the Lab” podcast is available on your favorite podcast platforms. Subscribe on your preferred app to stay up to date and never miss an episode.

Video

Mayo Clinic Laboratories

This post was authored by the Marketing Team at Mayo Clinic Laboratories.